SmartMatch Study for Rare Gynecologic Cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a new approach called SmartMatch that looks at the unique traits of your tumor to find the best treatment for you. The goal is to see if this personalized approach is feasible and helpful for people with rare gynecologic cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a rare gynecologic cancer that has spread, cannot be removed by surgery, or needs more treatment.
- You have a recent tumor sample (from surgery or biopsy) that can be tested.
- You are generally well enough to receive cancer treatment (performance status 0-2).
- You agree to let the study team review your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This study looks at very rare types of female reproductive system tumors. It collects tissue samples to better understand these cancers. You may join if you have one of these rare tumors and have had surgery.
This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study is collecting tissue and blood samples from people with rare gynecologic cancers (like certain ovarian tumors, uterine sarcomas, and vulvar cancer) to understand their genetic makeup. The goal is to find better ways to manage and treat these rare cancers in the future.
Hear when a new Malignant Female Reproductive System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.